Literature DB >> 19298363

Depression in chronic pain patients: prevalence and measurement.

Helen Poole1, Susie White, Chantal Blake, Peter Murphy, Ros Bramwell.   

Abstract

This study aimed to: (1) determine prevalence of depression in patients referred to specialist pain services using the Structured Clinical Interview (SCID) diagnostic interview, (2) compare results on the Beck Depression Inventory II (BDI-II) with the SCID to determine the utility of the BDI-II as a screening tool in this population. Thirty-six participants were recruited, mainly women, with a mean age = 47.83 years (standard deviation = 12.85 years), who were heterogeneous with regard to their pain. All completed the BDI-II and SCID. The SCID diagnosed 26 (72%) cases of depression. BDI-II scores showed 31 (86%) that reported at least mild depression. Agreement between BDI-II scores over threshold for mild depression and SCID diagnosis were assessed by Cohen's kappa (= 0.6). ROC analysis for BDI-II scores against SCID diagnosis gave a large area under the curve (0.97, 95% confidence interval 0.93 to 1.02), suggesting BDI-II is an excellent screen for this population, although the curve was unusual in that sensitivity was high even when the false positive rate was zero. ROC analysis suggested 22 or above as an optimum cut-off score for depression on the BDI-II-higher than for a general population sample. It has been suggested that the BDI overestimates incidence of depression in pain patients, but this study confirmed through diagnostic interview the very high incidence of depression in this population. It is therefore questionable whether there is value in screening referrals for depression. When using BDI-II for screening, audit or evaluation purposes with a pain clinic population, we suggest a cut-off of 22 or above.

Entities:  

Mesh:

Year:  2009        PMID: 19298363     DOI: 10.1111/j.1533-2500.2009.00274.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  34 in total

1.  Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.

Authors:  Geoffroy Laumet; Wenjun Zhou; Robert Dantzer; Jules D Edralin; XiaoJiao Huo; David P Budac; Jason C O'Connor; Anna W Lee; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Brain Behav Immun       Date:  2017-07-11       Impact factor: 7.217

Review 2.  Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders.

Authors:  George M Slavich; Julia Sacher
Journal:  Psychopharmacology (Berl)       Date:  2019-07-29       Impact factor: 4.530

3.  SIRT1 Decreases Emotional Pain Vulnerability with Associated CaMKIIα Deacetylation in Central Amygdala.

Authors:  Chenghua Zhou; Yuqing Wu; Xiaobao Ding; Naihao Shi; Youqin Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2020-01-31       Impact factor: 6.167

4.  Mood Spectrum Disorders and Perception of Pain.

Authors:  Antonella Ciaramella
Journal:  Psychiatr Q       Date:  2017-12

5.  The Characteristics of Pain in Patients Diagnosed with Depression and Heart Failure.

Authors:  Christine Haedtke; Marianne Smith; John VanBuren; Dawn Klein; Carolyn Turvey
Journal:  Pain Manag Nurs       Date:  2017-08-23       Impact factor: 1.929

Review 6.  From stress to inflammation and major depressive disorder: a social signal transduction theory of depression.

Authors:  George M Slavich; Michael R Irwin
Journal:  Psychol Bull       Date:  2014-01-13       Impact factor: 17.737

7.  An unresolved discussion: presence of premature ejaculation and erectile dysfunction in lumbar disc hernia.

Authors:  Cenk Murat Yazici; Banu Sarifakioglu; Aliye Guzelant; Polat Turker; Ozkan Ates
Journal:  Int Urol Nephrol       Date:  2013-03-30       Impact factor: 2.370

8.  Mild Depression in Low Back Pain: the Interaction of Thought Suppression and Stress Plays a Role, Especially in Female Patients.

Authors:  Kerstin Konietzny; Omar Chehadi; Irmgard Streitlein-Böhme; Herbert Rusche; Roland Willburger; Monika Ilona Hasenbring
Journal:  Int J Behav Med       Date:  2018-04

9.  Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling.

Authors:  Geoffroy Laumet; Jules Daniel Edralin; Angie Chi-An Chiang; Robert Dantzer; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Neuropsychopharmacology       Date:  2018-07-16       Impact factor: 7.853

10.  Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events.

Authors:  George M Slavich; Molly A Tartter; Patricia A Brennan; Constance Hammen
Journal:  Psychoneuroendocrinology       Date:  2014-07-18       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.